Expressivity of a common fragile site, fra(3)(p14.2), in patients with cancer and other diseases.
A population survey of a common folate-sensitive fragile site, fra(3)(p14.2), has been carried out on PHA-stimulated peripheral lymphocytes of patients with cancer and other diseases, under both culture conditions of folate deprivation and aphidicolin treatment. Overall findings regarding variability of expressivity due to age and sex were very similar to those obtained in a healthy population. The expression of fra(3)(p14.2) by folate deficient condition appeared hardly influenced by such exogenous factors as tobacco smoking habit, past histories of radiotherapy and chemotherapy, while it was associated with the unfavorable prognosis of cancers. Furthermore, proportion of those with higher expression was slightly but significantly larger in both lung and breast cancer patients. These findings suggest that some factors relevant to the expression of fra(3)(p14.2) may be associated with development and progression of certain kinds of cancer.
Murata
M
M
Division of Epidemiology, Chiba Cancer Center Research Institute, Japan.
Otsuka
M
M
Hayakawa
Y
Y
Takahashi
E
E
Tsuji
H
H
Hori
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D043283:Chromosome Fragile Sites; D002873:Chromosome Fragility; D002874:Chromosome Mapping; D002893:Chromosomes, Human, Pair 3; D005260:Female; D005494:Folic Acid Deficiency / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000235:genetics*; D016017:Odds Ratio; D011379:Prognosis; D012907:Smoking / Q000235:genetics; D016019:Survival Analysis